Pyridine-2,3-dicarboxylate, quinolinic acid, induces 1N4R Tau amyloid aggregation in vitro: Another evidence for the detrimental effect of the inescapable endogenous neurotoxin-Reference-Cited by-同舟云学术

Pyridine-2,3-dicarboxylate, quinolinic acid, induces 1N4R Tau amyloid aggregation in vitro: Another evidence for the detrimental effect of the inescapable endogenous neurotoxin

Published:2020-01 Issue: Volume:315 Page:108884
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Esmaeili Sajjad,Ghobadi Nazanin,Akbari Vali,Moradi Sajad,Shahlaie Mohsen,Ghobadi Sirous,Jalalvand Ali Reza,Amani Mojtaba,Khodarahmi Reza

Funder

Kermanshah University of Medical Sciences

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference90 articles.

1. Amyloid Fibrils;Rambaran,2008

2. Appraisal of role of the polyanionic inducer length on amyloid formation by 412-residue 1N4R Tau protein: a comparative study;Jangholi;Arch. Biochem. Biophys.,2016

3. Islet amyloid and type 2 diabetes mellitus;Höppener;N. Engl. J. Med.,2000

4. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics;Hardy;Science,2002

5. Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neurons;Pallo;Neurosci. Lett.,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atomic Force Microscopy Applied to the Study of Tauopathies;ACS Chemical Neuroscience;2024-02-02

2. Implications of ALS-Associated Mutations on Biochemical and Biophysical Features of hSOD1 and Aggregation Formation;Biochemical Genetics;2024-01-09

3. Tryptophan metabolism in health and disease;Cell Metabolism;2023-08

4. Investigation of the Effect of Pyrogallol on the Formation of Amylin Amyloid Fibrils as a Strategy for the Treatment of Type 2 Diabetic Patients: A Theoretical and Experimental Study;Journal of Fluorescence;2023-05-17

5. Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson’s Disease;ACS Chemical Neuroscience;2023-03-29